UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 114

of 'Clinical features, evaluation, and treatment of retroperitoneal soft tissue sarcoma'

114
TI
Management of recurrent retroperitoneal sarcoma.
AU
Gyorki DE, Brennan MF
SO
J Surg Oncol. 2014 Jan;109(1):53-9. Epub 2013 Oct 24.
 
Approximately 15% of soft tissue sarcomas are retroperitoneal. The occult location and anatomic complexity results in local recurrences in the majority of patients. Predictors of recurrence include histological subtype, completeness of resection, and the hospital case volume. The most significant predictor of outcome following local recurrence is the resectability of the recurrent disease. An understanding of the implication of tumor biology on outcomes is essential in determining optimal management for patients with recurrent retroperitoneal sarcoma.
AD
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
PMID